Latest News

Most readers would already be aware that Cluster TechnologyLtd's (TSE:4240) stock increased significantly by 19% over...

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...

Sumitomo Rubber Industries, Ltd. ( TSE:5110 ) has announced that it will pay a dividend of ¥35.00 per share on the 30th...

There wouldn't be many who think Fukutome Meat Packers, Ltd.'s ( TSE:2291 ) price-to-sales (or "P/S") ratio of 0.1x is...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

SHO-BOND Holdings Co.,Ltd. ( TSE:1414 ) has announced that it will pay a dividend of ¥82.00 per share on the 10th of...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...

Let's talk about the popular Korea Electric Power Corporation ( KRX:015760 ). The company's shares saw significant...

Daiseki Eco. Solution Co., Ltd. ( TSE:1712 ) shares have continued their recent momentum with a 49% gain in the last...

Fixstars' (TSE:3687) stock is up by a considerable 18% over the past month. Given that the market rewards strong...

Argo Investments Limited's ( ASX:ARG ) price-to-earnings (or "P/E") ratio of 27.3x might make it look like a sell right...

Key Insights Perenti's estimated fair value is AU$5.74 based on 2 Stage Free Cash Flow to Equity Perenti is estimated...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...

As Australian shares experience a slight dip following recent bullish activity, the market remains a dynamic landscape influenced by global factors such as gold prices and geopolitical events. In this context, identifying promising stocks requires careful consideration of financial health and growth potential. Penny stocks, often associated with smaller or newer companies, continue to offer intriguing opportunities for investors seeking affordability combined with the possibility of...

Trying to decide what to do with Brunello Cucinelli stock? You are definitely not alone. The luxury apparel maker is a favorite of both style mavens and market-watchers, but lately, it has been a bit of a roller coaster ride for shareholders. Just over the past year, the stock has dipped by 4.4%, with even sharper drops seen year-to-date, down 13.9%. Pull back the lens, however, and the story changes. Cucinelli has delivered an impressive 87.2% return over three years and a massive 240.9%...

Thinking about what to do with MAC Copper stock? You are not alone. The company’s recent price trajectory has caught the eye of both cautious investors and optimistic speculators. In the last year, the stock slipped by 12.2%, but look further back and the story changes. MAC Copper is still up 24.4% over the last three years and an impressive 15.7% so far this year. If you have been watching for signs of life after a slow month or two, the near-flat 30-day and 7-day returns show the market...

If you are looking at Luye Pharma Group’s stock and wondering whether now is the right time to buy, hold, or even take some profit, you are not alone. The company’s recent price swings have caught the attention of both seasoned investors and cautious newcomers. In just the past week, the stock climbed by an impressive 7.7%, a move that stands out after a volatile month that saw shares drop by 7.4%. Despite these ups and downs, long-term holders are likely noticing the big picture. Since the...

If you're eyeing China CITIC Bank's stock and wondering if now is the right time to make a move, you're not alone. Many investors are trying to size up what’s driving this bank’s surprising momentum, especially in the midst of shifting market sentiment. Despite some recent softness, with a drop of 1.8% over the past week and a 5.7% slip over the last month, the longer-term numbers tell a different story. Year to date, China CITIC Bank’s stock is up a strong 26.5%, and if you zoom out further,...

Ovid Therapeutics has grabbed investor attention after unveiling encouraging Phase 1 results for its next-generation epilepsy drug, OV329. In addition to the promising data, the company secured $175 million in new financing, extending its cash runway. See our latest analysis for Ovid Therapeutics. After surging on the back of positive Phase 1 data and a major private financing announcement, Ovid Therapeutics has seen renewed bullishness, with momentum building over the short term. While the...

Wondering what to do with China Construction Bank stock? You are definitely not alone. Whether you have watched its price climb over 100% in the last three or five years, or you are noting the recent dip over the past month, the ride has been anything but dull. Year to date, shares are still up an impressive 20.7%, and over the past year, investors have enjoyed a hefty 26.1% return. Even with a slide of -5.0% in the last 30 days, long-term performance shows plenty of resilience and perhaps...

If you own Colruyt Group stock, or are watching from the sidelines for the right entry point, you are not alone. The company’s recent performance has definitely raised a few eyebrows and stirred up some debate. Over the past year, Colruyt shares have shed 22.5%, continuing a downward trend that deepened with a 16.2% drop over the last 30 days alone. Year to date, the stock is off by 12.8%. That sounds rough, but if you zoom out a bit, you’ll see a three-year return of 53.6%, demonstrating...

Thinking about buying or holding Nokian Renkaat Oyj stock? You are not alone. This Finnish tire maker has been on many investors’ watchlists lately, especially after its rollercoaster ride on the stock market. Just this week, the price ticked up by 2.7%, which grabbed some attention. If you zoom out, the picture is more nuanced. Over the past month the stock is down by just 0.7%, and the year-to-date return sits at a modest 5.7%. Looking back even farther, there is a clear hangover from years...

Thinking about what to do with Talanx stock? You’re not alone. Investors have been watching its remarkable journey with keen interest. Over the past five years, Talanx has handed shareholders a staggering 381.1% return, including a 60.8% gain in just the last year. Even in the past week and month, the stock continued to inch upward, rising 2.2% and 2.4% respectively. Such persistent strength hints at more than just market optimism, especially as insurance giants like Talanx navigate changing...